BR100 Decreased By (-0.02%)
BR30 Increased By (0.11%)
KSE100 Decreased By (-0.08%)
KSE30 Increased By (0.02%)
AGHA 7.73 Decreased By ▼ -0.19 (-2.4%)
BECO 5.19 Decreased By ▼ -0.01 (-0.19%)
BML 57.61 Decreased By ▼ -1.64 (-2.77%)
BOP 33.50 Decreased By ▼ -0.18 (-0.53%)
CNERGY 10.22 Increased By ▲ 0.41 (4.18%)
CSIL 5.35 Decreased By ▼ -0.07 (-1.29%)
FCCL 54.14 Increased By ▲ 0.62 (1.16%)
FFL 16.39 Decreased By ▼ -0.29 (-1.74%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 7.19 Decreased By ▼ -0.16 (-2.18%)
KOSM 5.57 Decreased By ▼ -0.04 (-0.71%)
LOTCHEM 28.88 Decreased By ▼ -0.23 (-0.79%)
MLCF 96.00 Increased By ▲ 0.50 (0.52%)
NBP 202.50 Decreased By ▼ -1.85 (-0.91%)
NCPL 56.73 Decreased By ▼ -1.51 (-2.59%)
NPL 67.00 Decreased By ▼ -0.79 (-1.17%)
OGDC 318.50 Increased By ▲ 0.56 (0.18%)
PACE 10.67 Decreased By ▼ -0.04 (-0.37%)
PAEL 41.44 Decreased By ▼ -0.39 (-0.93%)
PIBTL 16.50 No Change ▼ 0.00 (0%)
PPL 221.58 Increased By ▲ 1.84 (0.84%)
PRL 47.66 Increased By ▲ 3.07 (6.88%)
PTC 70.90 Increased By ▲ 0.13 (0.18%)
SSGC 28.88 Decreased By ▼ -0.05 (-0.17%)
TBL 9.75 Decreased By ▼ -0.09 (-0.91%)
TELE 8.86 Increased By ▲ 0.10 (1.14%)
TPL 17.21 Increased By ▲ 0.76 (4.62%)
TPLP 12.34 Increased By ▲ 0.24 (1.98%)
TREET 22.46 Decreased By ▼ -0.34 (-1.49%)
TRG 59.70 Decreased By ▼ -0.33 (-0.55%)
Topic

CureVac

European shares slip

European shares slip

Published 18 Jun, 2021 04:16am
AMSTERDAM/LONDON: European shares fell from record highs on Thursday, tracking declines on Wall Street after the...
CureVac starts review process in Switzerland for COVID-19 vaccine hopeful

CureVac starts review process in Switzerland for COVID-19 vaccine hopeful

Published 19 Apr, 2021 06:10pm
  • Switzerland, which to date has approved COVID-19 shots from Pfizer, Moderna and Johnson & Johnson, has placed orders for five million doses of CureVac's vaccine. It is a so-called mRNA vaccine, like those from Moderna and Pfizer that are already on the market.
  • "The duration of the rolling review will depend on the completeness of the data submitted by CureVac and the results of the clinical trials, and cannot therefore be predicted," Swissmedic said.
CureVac says interest in its COVID-19 vaccine on the rise

CureVac says interest in its COVID-19 vaccine on the rise

Updated 15 Apr, 2021 07:25pm
  • The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.
  • Europe's choppy vaccine rollout hit more trouble this week after J&J suspended shipments of its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over very rare cases of blood clotting.
EU approves Johnson & Johnson Covid vaccine

EU approves Johnson & Johnson Covid vaccine

Published 12 Mar, 2021 10:12am
  • The EU has so far approved three vaccines -- Pfizer-BioNTech, Moderna and AstraZeneca-Oxford. Three other vaccines are under "rolling review" by the Amsterdam-based EMA -- Novavax, CureVac and Russia's Sputnik.
Latest on worldwide spread of the coronavirus

Latest on worldwide spread of the coronavirus

Published 18 Jan, 2021 10:26am
  • Portugal's public health system is on the verge of collapsing as hospitals in the areas worst-affected by a worrying surge in coronavirus cases are quickly running out of intensive care beds to treat COVID-19 patients.
Germany secured 50mn vaccine doses from CureVac, BioNTech on top of EU supplies

Germany secured 50mn vaccine doses from CureVac, BioNTech on top of EU supplies

Published 08 Jan, 2021 08:17pm
  • The ministry official, speaking on condition of anonymity, said Germany signed a memorandum of understanding with CureVac on Aug. 31 for the supply of 20 million doses of its vaccine under development.
  • The internal health ministry document dated Jan. 7 and seen by Reuters had the same figures.
Loading...